Endo 'Made Out Like A Bandit' With Opana Deal, Buyers Say
Opana ER buyers told an Illinois federal jury Thursday that Endo Pharmaceuticals raked in profits by striking an unlawful settlement to delay a generic competitor for its opioid, saying the deal...To view the full article, register now.
Already a subscriber? Click here to view full article